Visit the Micromeritics web site
Click on the advert above to visit the company web site

Product category: Nucleic acid sequencing and synthesis
News Release from: Applied Biosystems
Edited by the Laboratorytalk Editorial Team on 06 January 2006

AB invests in VisiGen Biotechnologies

Request your FREE weekly copy of the Laboratorytalk email newsletter. News about Nucleic acid sequencing and synthesis and more every issue. Click here for details.

Applied Biosystems has agreed to invest in, and collaborate with, VisiGen Biotechnologies, a privately held next-generation sequencing technology company

VisiGen's technological approach to DNA sequencing is based on the ability to analyse a single molecule of DNA in real time, which has the potential to drastically reduce the cost of sequencing and significantly improve throughput compared to existing commercially available technologies Their solution could provide a quantum leap in the scope and scale of research aimed at uncovering the genetic basis of common diseases such as cancer, heart disease and diabetes

"Applied Biosystems continues to extensively evaluate potential next-generation sequencing technologies.

"We believe that the quality of VisiGen's science and the progress towards the development of single-molecule sequencing technology is quite impressive," explained Catherine Burzik, president of Applied Biosystems.

Susan Harding, president and CEO of VisiGen, continued: "VisiGen's approach of monitoring parallel arrays of single molecules could allow large-scale sequencing projects in the areas of cancer and other diseases and could make sequencing-based targeted medicine a reality.

"This investment by Applied Biosystems, and its expertise in DNA sequencing, makes it an ideal partner for us as we work towards commercialisation.".

Applied Biosystems: contact details and other news
Email this article to a colleague
Register for the free Laboratorytalk email newsletter
Laboratorytalk Home Page

Search the Pro-Talk network of sites

Visit the Micromeritics web site